Victoria Stavrou

Medicine & Life Sciences

1. BCT-100 100%
2. Arginase 95%
3. Arginine 83%
4. Natural Killer T-Cells 52%
5. Immunotherapy 51%
6. Acute Myeloid Leukemia 49%
7. T-Lymphocytes 45%
8. Leukemia 36%
9. Young Adult 35%
10. Antigens 28%
11. Safety 25%
12. Up-Regulation 21%
13. Vorinostat 20%
14. Azacitidine 19%
15. Child 19%
16. Neoplasms 16%
17. Large Neutral Amino Acid-Transporter 1 13%
18. Sialic Acid Binding Ig-like Lectin 3 12%
19. Pediatrics 12%
20. Argininosuccinate Synthase 11%
21. Chimeric Antigen Receptors 9%
22. Myeloid-Derived Suppressor Cells 9%
23. Serum Amyloid A Protein 9%
24. Acute-Phase Proteins 8%
25. Testicular Neoplasms 8%
26. Myeloid Cells 7%
27. In Vitro Techniques 6%
28. Immunosuppressive Agents 6%
29. Lymphoma 6%
30. Immunity 5%
31. Cell Death 5%
32. Patient Selection 5%
33. Amino Acids 5%
34. Disease Progression 5%